These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparing progression of non-functioning pituitary adenomas in hypopituitarism patients with and without long-term GH replacement therapy. Olsson DS; Buchfelder M; Schlaffer S; Bengtsson BA; Jakobsson KE; Johannsson G; Nilsson AG Eur J Endocrinol; 2009 Nov; 161(5):663-9. PubMed ID: 19734242 [TBL] [Abstract][Full Text] [Related]
5. Replacement with sex steroids in hypopituitary men and women: implications for gender differences in morbidities and mortality. Donald DM; McDonnell T; O'Reilly MW; Sherlock M Rev Endocr Metab Disord; 2024 Oct; 25(5):839-854. PubMed ID: 39370498 [TBL] [Abstract][Full Text] [Related]
6. Medical management of hypopituitarism in patients with pituitary adenomas. Arafah BM Pituitary; 2002; 5(2):109-17. PubMed ID: 12675508 [TBL] [Abstract][Full Text] [Related]
7. Safety aspects of growth hormone replacement. Waterhouse M; Monson JP Front Horm Res; 2005; 33():209-221. PubMed ID: 16166764 [No Abstract] [Full Text] [Related]
9. Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults. van Varsseveld NC; van Bunderen CC; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML Pituitary; 2016 Aug; 19(4):381-90. PubMed ID: 27048484 [TBL] [Abstract][Full Text] [Related]
16. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database. Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P; Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692 [TBL] [Abstract][Full Text] [Related]
17. Metabolic Syndrome in Hypopituitarism. Miljić D; Popovic V Front Horm Res; 2018; 49():1-19. PubMed ID: 29895033 [TBL] [Abstract][Full Text] [Related]
18. Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy. Svensson J; Bengtsson BA; Rosén T; Odén A; Johannsson G J Clin Endocrinol Metab; 2004 Jul; 89(7):3306-12. PubMed ID: 15240607 [TBL] [Abstract][Full Text] [Related]
19. The impact of glucocorticoid replacement on bone mineral density in patients with hypopituitarism before and after 2 years of growth hormone replacement therapy. Ragnar Agnarsson H; Johannsson G; Ragnarsson O J Clin Endocrinol Metab; 2014 Apr; 99(4):1479-85. PubMed ID: 24423362 [TBL] [Abstract][Full Text] [Related]
20. Treatment of the adult growth hormone deficiency syndrome with growth hormone: What are the implications for other hormone replacement therapies for hypopituitarism? Fierro G; Hoffman AR Growth Horm IGF Res; 2020 Jun; 52():101316. PubMed ID: 32229369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]